Trastuzumab related cardiotoxicity in nonmetastatic breast cancer: A real-world scenario

医学 曲妥珠单抗 心脏毒性 射血分数 内科学 乳腺癌 蒽环类 无症状的 肿瘤科 心脏病学 心力衰竭 入射(几何) 癌症 化疗 物理 光学
作者
S. Shrivastva,Sant Prasad,Rachana Chennamaneni,B. Stalin,M.L. Konatam,Sadashivudu Gundeti
出处
期刊:Annals of Oncology [Elsevier BV]
卷期号:30: iii69-iii69 被引量:1
标识
DOI:10.1093/annonc/mdz101.015
摘要

Background: Trastuzumab, a humanized monoclonal antibody significantly improves outcomes in Her2 neu positive breast cancer. The incidence of cardiotoxicity with trastuzumab is approximately 8-10%. The present study was designed to analyze the incidence and risk factors associated with trastuzmab related cardiotoxicity. Methods: The present study was a single institutional retrospective analysis of the incidence of trastuzumab induced cardiotoxicity in nonmetastatic invasive breast cancer from January 2011 to December 2018. Trastuzumab induced cardiotoxicity (TIC) was defined as symptomatic heart failure or asymptomatic decline in left ventricular ejection fraction (LVEF) by > 10% or LVEF < 50%. Risk factors analysed were BMI (≥30 vs < 30), history of diabetes, hypertension, coronary artery disease (CAD) (yes or no), left sided radiotherapy (RT) and prior anthracycline (yes or no). Results: Data of 246 patients with Her2 neu positive breast cancer was collected. Of these, 117(47.5%) received trastuzumab. The median age at presentation was 51 years (range,28-72). Of 117 patients who received adjuvant trastuzumab TIC was seen in 16(13.6%) patients, asymptomatic LV dysfunction in 9.4% and symptomatic LV dysfunction in 4.2% patients. The median baseline ejection fraction of 65% (range, 56 - 72). The median time to development of TIC was 18.5 (range, 3-52) weeks and median trastuzumab cycle for TIC was 6 (range, 2-16). Presence of ≥ 2 risk factors (20%) had significant impact on incidence of TIC compared to < 2 risk factors (p = 0.04). 10 (62.5%) patients were rechallenged with trastuzumab and 6(37.5%) discontinued trastuzumab. Following rechallenge 1 patient developed asymptomatic decline in EF and 1 developed symptomatic heart failure and were stopped completely. No cardiacrelated mortality was seen.Table214P Risk factors in relation to TICRisk factorTIC PresentTIC absentp ValueBMI ≥ 30 < 302 1414 780.54History of diabetes Yes No3 1321 800.88History of hypertension Yes No8 831 700.2CAD Yes No1 152 990.8Left side RT Yes No9 723 780.012Prior anthracycline Yes No13 365 360.29 Open table in a new tab Conclusions: Approximately 14% developed TIC which was higher in real-world population compared to that seen in clinical trials. Left sided RT to chest and presence of 2 or more risk factors had significant impact on development of TIC. Stringent monitoring of cardiac function to avoid cardiotoxicity and prompt resumption of trastuzumab following recovery may further improve outcomes in nonmetastatic breast cancer. Legal entity responsible for the study: Department of Medical Oncology, NIMS, Punjagutta, Hyderabad, India. Funding: Has not received any funding. Disclosure: All authors have declared no conflicts of interest.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
1秒前
Beagle完成签到,获得积分10
1秒前
SciGPT的应助被如意2023采纳,获得10
1秒前
体贴千山完成签到,获得积分10
2秒前
李健的应助被快乐的鱼采纳,获得10
2秒前
完美世界的应助被徐枘采纳,获得10
2秒前
ren完成签到,获得积分10
3秒前
丹丹完成签到,获得积分10
4秒前
NANA完成签到 ,获得积分10
4秒前
4秒前
初海歌发布了新的文献求助10
4秒前
天天快乐的应助被淡然妙松采纳,获得10
4秒前
4秒前
4秒前
Felicia发布了新的文献求助10
5秒前
vnewgnl的应助被adamchris采纳,获得10
5秒前
5秒前
keyan发布了新的文献求助10
6秒前
drleslie完成签到 ,获得积分10
6秒前
隆隆完成签到,获得积分20
6秒前
麻辣王子完成签到 ,获得积分10
6秒前
7秒前
7秒前
molihuakai的应助被yizhiyang采纳,获得10
7秒前
HY完成签到,获得积分10
7秒前
manstein完成签到,获得积分10
7秒前
XSY完成签到 ,获得积分10
8秒前
8秒前
舒适鸣凤的应助被当你采纳,获得10
8秒前
淡定的伊完成签到 ,获得积分10
9秒前
隐形曼青的应助被三又一十八采纳,获得10
9秒前
2397完成签到,获得积分20
10秒前
今后的应助被淡定的板栗采纳,获得10
10秒前
huoo发布了新的文献求助10
11秒前
11秒前
做完实验打boss完成签到,获得积分10
11秒前
臭屁发布了新的文献求助10
11秒前
Nole的应助被精明丹妗采纳,获得10
11秒前
赵妍发布了新的文献求助10
11秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Handbook of Sport Coaching Research 1000
Orthognathic Surgery - 2 Volume Set 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8193335
求助须知:如何正确求助?哪些是违规求助? 9579489
关于积分的说明 21865844
捐赠科研通 7792843
什么是DOI,文献DOI怎么找? 3437210
关于科研通互助平台的介绍 2560687
邀请新用户注册赠送积分活动 2483996